Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

PTC Therapeutics reported $-166590000 in Pre-Tax Profit for its fiscal quarter ending in September of 2023.

Pre Tax Profit Change Date
Acadia Pharmaceuticals USD -52143000 58.49M Sep/2023
Alnylam Pharmaceuticals USD 150.74M 424.95M Sep/2023
BioCryst Pharmaceuticals USD -35819000 38.77M Sep/2023
Bluebird Bio USD -71731000 1.26M Sep/2023
Cytokinetics USD -129422000 785K Sep/2023
Daiichi Sankyo JPY 49.96B 2.17B Sep/2023
Enanta Pharmaceuticals USD -29517000 5.33M Sep/2023
Esperion Therapeutics USD -41250000 8.68M Sep/2023
Incyte USD 319.15M 14.94M Sep/2023
Ionis Pharmaceuticals USD -141000000 64M Sep/2023
PTC Therapeutics USD -166590000 70.89M Sep/2023
Roche Holding CHF 10.33B 1.48B Jun/2023
Sarepta Therapeutics USD -33174000 18.59M Sep/2023
TG Therapeutics USD 113.93M 161.54M Sep/2023
Ultragenyx Pharmaceutical USD -158999000 97K Sep/2023
Xencor USD -24268000 2.31M Sep/2023